» Articles » PMID: 19639350

Outbreak of Multiresistant Acinetobacter Baumannii in a Polyvalent Intensive Care Unit: Clinical, Epidemiological Analysis and PFGE-printing Evolution

Overview
Publisher Springer
Date 2009 Jul 30
PMID 19639350
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

An outbreak of multidrug-resistant Acinetobacter baumannii (MRAB) occurred over the course of a 27-week period in our adult polyvalent intensive care unit (ICU). Twenty-one patients were affected, and 72 strains were identified from different clinical samples. The strains were resistant to all antibiotics except for colistin and ampicillin/sulbactam. Forty-nine MRAB strains collected from 18 patients were analysed by pulsed-field gel electrophoresis (PFGE). This analysis revealed four highly-related PFGE types (genetic similarity index >90%) termed 1, 2, 3 and 4, that were isolated in 13, seven, one, and three patients, respectively. A single PFGE type was identified from five of ten patients with successive isolation of MRAB; in the other five patients, two or three PFGE types were detected. This suggested phased evolution of PFGE types 2, 3 and 4 from PFGE type 1. Global mortality was high (13 patients; 62%). Non-survivors had higher APACHE II scores than survivors on the date that MRAB was isolated (OR = 1.57; 95% CI [1.02, 2.44]). The outbreak was controlled after implementation of an extensive infection control program.

Citing Articles

Treatment and Management of Pneumonia: Lessons Learned from Recent World Event.

Rangel K, De-Simone S Infect Drug Resist. 2024; 17:507-529.

PMID: 38348231 PMC: 10860873. DOI: 10.2147/IDR.S431525.


Association between antibiotic pressure and the risk of colonization/infection by multidrug-resistant Acinetobacter baumannii complex: a time series analysis.

Huertas Vaquero M, Asencio Egea M, Carranza Gonzalez R, Padilla Serrano A, Conde Garcia M, Tenias Burillo J Rev Esp Quimioter. 2021; 34(6):623-630.

PMID: 34610732 PMC: 8638773. DOI: 10.37201/req/061.2021.


Task force on management and prevention of Acinetobacter baumannii infections in the ICU.

Garnacho-Montero J, Dimopoulos G, Poulakou G, Akova M, Cisneros J, De Waele J Intensive Care Med. 2015; 41(12):2057-75.

PMID: 26438224 DOI: 10.1007/s00134-015-4079-4.


Predictors of mortality in solid-organ transplant recipients with infections caused by Acinetobacter baumannii.

Liu H, Ye Q, Wan Q, Zhou J Ther Clin Risk Manag. 2015; 11:1251-7.

PMID: 26345195 PMC: 4551305. DOI: 10.2147/TCRM.S91277.


Analysis of genes encoding penicillin-binding proteins in clinical isolates of Acinetobacter baumannii.

Cayo R, Rodriguez M, Espinal P, Fernandez-Cuenca F, Ocampo-Sosa A, Pascual A Antimicrob Agents Chemother. 2011; 55(12):5907-13.

PMID: 21947403 PMC: 3232777. DOI: 10.1128/AAC.00459-11.


References
1.
Nei M, Li W . Mathematical model for studying genetic variation in terms of restriction endonucleases. Proc Natl Acad Sci U S A. 1979; 76(10):5269-73. PMC: 413122. DOI: 10.1073/pnas.76.10.5269. View

2.
Wendt C, DIETZE B, Dietz E, Ruden H . Survival of Acinetobacter baumannii on dry surfaces. J Clin Microbiol. 1997; 35(6):1394-7. PMC: 229756. DOI: 10.1128/jcm.35.6.1394-1397.1997. View

3.
Garnacho-Montero J, Ortiz-Leyba C, Fernandez-Hinojosa E, Aldabo-Pallas T, Cayuela A, Marquez-Vacaro J . Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings. Intensive Care Med. 2005; 31(5):649-55. DOI: 10.1007/s00134-005-2598-0. View

4.
Das I, Lambert P, Hill D, Noy M, Bion J, Elliott T . Carbapenem-resistant Acinetobacter and role of curtains in an outbreak in intensive care units. J Hosp Infect. 2002; 50(2):110-4. DOI: 10.1053/jhin.2001.1127. View

5.
Garcia-Garmendia J, Ortiz-Leyba C, Garnacho-Montero J, Jimenez-Jimenez F, Barrero-Almodovar A, Gili-Miner M . Risk factors for Acinetobacter baumannii nosocomial bacteremia in critically ill patients: a cohort study. Clin Infect Dis. 2001; 33(7):939-46. DOI: 10.1086/322584. View